173 related articles for article (PubMed ID: 20038365)
1. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].
Ballester I; Silvestre JF; Pérez-Crespo M; Lucas A
Actas Dermosifiliogr; 2009 Dec; 100(10):883-7. PubMed ID: 20038365
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis.
Murray ML; Cohen JB
Clin Exp Dermatol; 2007 Jan; 32(1):23-7. PubMed ID: 17059445
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis.
Dias-Polak D; Bergman R; Avitan-Hersh E
J Dermatolog Treat; 2019 Feb; 30(1):49-51. PubMed ID: 29683760
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients.
Heller M; Shin HT; Orlow SJ; Schaffer JV
Br J Dermatol; 2007 Jul; 157(1):127-32. PubMed ID: 17489974
[TBL] [Abstract][Full Text] [Related]
5. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
[TBL] [Abstract][Full Text] [Related]
6. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Garritsen FM; Roekevisch E; van der Schaft J; Deinum J; Spuls PI; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1905-12. PubMed ID: 25752497
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil is effective in the treatment of atopic dermatitis.
Grundmann-Kollmann M; Podda M; Ochsendorf F; Boehncke WH; Kaufmann R; Zollner TM
Arch Dermatol; 2001 Jul; 137(7):870-3. PubMed ID: 11453805
[TBL] [Abstract][Full Text] [Related]
8. Treatment of atopic eczema with oral mycophenolate mofetil.
Neuber K; Schwartz I; Itschert G; Dieck AT
Br J Dermatol; 2000 Aug; 143(2):385-91. PubMed ID: 10951150
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review.
Prussick L; Plotnikova N; Gottlieb A
J Drugs Dermatol; 2016 Jun; 15(6):715-8. PubMed ID: 27272078
[TBL] [Abstract][Full Text] [Related]
11. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.
Brill AK; Ott SR; Geiser T
Respiration; 2013; 86(5):376-83. PubMed ID: 23295253
[TBL] [Abstract][Full Text] [Related]
12. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
Haeck IM; Knol MJ; Ten Berge O; van Velsen SG; de Bruin-Weller MS; Bruijnzeel-Koomen CA
J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in primary central nervous system vasculitis.
Salvarani C; Brown RD; Christianson TJ; Huston J; Giannini C; Miller DV; Muratore F; Hunder GG
Semin Arthritis Rheum; 2015 Aug; 45(1):55-9. PubMed ID: 25800827
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
[TBL] [Abstract][Full Text] [Related]
16. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
17. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
19. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
Greiner K; Varikkara M; Santiago C; Forrester JV
Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
[TBL] [Abstract][Full Text] [Related]
20. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C
J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
